Patient and Physician Behavior
Featured Topics
Lead story
Other featured articles
-
Prescription Opioid Use in General and Pediatric Emergency Departments
Children, adolescents, and young adults treated in pediatric emergency departments are much less likely to be prescribed opioids compared to patients of similar age and ailment treated at general EDs.
Posted in -
Extended-Release Formulation and Medication Adherence
Suboptimal adherence to chronic medications undermines treatment effectiveness and costs the U.S. as much as $289 billion annually. This is the first study to analyze the impact of extended-release formulations on long-term adherence.
Posted in -
Opioid Prescribing Decreases After Learning of a Patient’s Fatal Overdose
Results of the randomized trial show opioid prescribing decreases after a clinician learns of a patient’s fatal overdose.
Posted in -
Traditional Vaccination Playbook Doesn’t Work with COVID
New study finds financial incentives and other behavioral nudges made little difference among certain groups.
Posted in
About this section
Patients as well as providers must take responsibility in improving healthcare, but human fallibility can impede success. The Schaeffer Center fosters supportive and effective ways to improve the decision-making of all parties for healthier results.
Our Experts On Patient and Physician Behavior
Our Work In Patient and Physician Behavior
-
Association of Fatal Overdose Notification Letters With Prescription of Benzodiazepines
New research builds on a landmark USC Schaeffer Center study aimed at reducing opioid overprescribing.
Categorized in -
‘Nudges’ to Reduce Opioid Overuse Also Decrease Inappropriate Benzodiazepine Prescriptions
Informing physicians when a patient dies of an overdose may provide the needed “nudge” to improve prescribing practices.
Categorized in -
Characterization of Cannabis Products Purchased for Medical Use in New York State
Schaeffer Center researchers analyzed point-of-sale data from nearly 17,000 medical cannabis patients making 80,000 purchases.
Categorized in -
Patient Preference for Medical Cannabis Products in the Absence of Clinical Guidelines
New analysis of New York data finds considerable variability in patient product choice, even for patients with the same condition.
Categorized in -
Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer
Are racial differences in symptom burden during the first year of adjuvant endocrine therapy (AET) associated with differences in adherence?
Categorized in -
Are Unequal Policies in Pre-Exposure Prophylaxis Uptake Needed to Improve Equality? An Examination Among Men Who Have Sex with Men in Los Angeles County
USC researchers examine tradeoffs between effectiveness and equality of PrEP.
Categorized in